May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Blockade of Endothelinergic Receptors and Prevention of PVR Lesions in the Dispase Model
Author Affiliations & Notes
  • M. Iribarne
    Facultad de Ciencias Biomedicas, Universidad Austral, Pilar, Argentina
  • V. Torbidoni
    Facultad de Ciencias Biomedicas, Universidad Austral, Pilar, Argentina
  • A. M. Suburo
    Facultad de Ciencias Biomedicas, Universidad Austral, Pilar, Argentina
  • Footnotes
    Commercial Relationships  M. Iribarne, None; V. Torbidoni, None; A.M. Suburo, None.
  • Footnotes
    Support  PICT 2004/21399. SECYT, RA.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 5249. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Iribarne, V. Torbidoni, A. M. Suburo; Blockade of Endothelinergic Receptors and Prevention of PVR Lesions in the Dispase Model. Invest. Ophthalmol. Vis. Sci. 2008;49(13):5249.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Retinal detachment (RD) and proliferative vitreoretinopathy (PVR) are characterized by severe glial remodeling. Retinal astrocytes normally express and accumulate endothelin-1 (ET-1), a small peptide involved in glial activation and development of fibrotic conditions. Since astrocytes also express the endothelinergic receptor ETR-B, we tested the effect of tezosentan, a mixed endothelinergic antagonist, on PVR-like lesions induced by dispase intravitreal injection in mice

Methods: : Male C57BL/6J mice were anesthetized and injected intravitreally with 0.3 U/µl dispase. Under these conditions, retinal folds and PVR-like membranes develop within a week. Mice received daily injections of tezosentan (10 mg/kg, sc, Actelion Pharmaceuticals, Switzerland), or saline solution. Control and treated animals were euthanatized on day 3 and 7. Retinas were used for detection of prepro-ET-1 and ETR-B mRNAs by RT-PCR, or for immunochemical detection of ET-1, ETR-B and GFAP.

Results: : Retinal expression of prepro-ET-1 and ETR-B mRNAs significantly increased 3 days after dispase intravitreal injection. In these retinas, astrocytes displayed stronger ET-1 and ETR-B than in controls. Astrocyte processes apparently invaded the vitreal space through discontinuities of the inner limiting membrane (ILM). One week after dispase injection, control mice showed large retinal detachments, extensive folding of the retina and had epi- and subretinal membranes. By contrast, animals receiving tezosentan, showed minimal retinal folding. Few epiretinal membranes appeared in tezosentan-treated animals, but subretinal membranes were still present. Subretinal membranes lacked ETB-R immunoreactivity, whereas epiretinal membranes and the boundary between these membranes and the retina displayed strong ETB-R immunoreactivivity.

Conclusions: : The ILM and astrocytes were early affected by intravitreal dispase injections. Astrocytes increased expression of ET-1 and ETR-B and seemed to be the first retinal cells involved in vitreal outgrowths. Treatment with an endothelinergic antagonist blocked retinal folding and growth of epiretinal membranes. Subretinal membranes were not affected, probably because they lack ETR-B.

Keywords: proliferative vitreoretinopathy • astrocyte • receptors: pharmacology/physiology 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×